JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB198684

Anti-SIGLEC15抗体

Anti-SIGLEC15 antibody

Be the first to review this product! Submit a review

|

(12 Publications)

Rabbit Polyclonal SIGLEC15 antibody. Suitable for IHC-P and reacts with Human samples. Cited in 12 publications. Immunogen corresponding to Synthetic Peptide within Human SIGLEC15.

查看别名

CD33L3, SIGLEC15, Sialic acid-binding Ig-like lectin 15, Siglec-15, CD33 antigen-like 3

2 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-SIGLEC15 antibody (AB198684)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-SIGLEC15 antibody (AB198684)

Immunohistochemical analysis of paraffin-embedded Human prostate cancer tissue labeling SIGLEC15 with ab198684 at 1/35 dilution.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-SIGLEC15 antibody (AB198684)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-SIGLEC15 antibody (AB198684)

Immunohistochemical analysis of paraffin-embedded Human tonsil cancer tissue labeling SIGLEC15 with ab198684 at 1/35 dilution.

关键信息

宿主种属

Rabbit

克隆

Polyclonal

亚型

IgG

不含载体蛋白

No

反应种属

Human

应用

IHC-P

applications

免疫原

Synthetic Peptide within Human SIGLEC15. The exact immunogen used to generate this antibody is proprietary information.

Q6ZMC9

反应性数据

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/25 - 1/100", "IHCP-species-notes": "<p></p>" }, "Rat": { "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" } } }

性能和储存信息

形式
Liquid
纯化工艺
Affinity purification Immunogen
存储溶液
pH: 7.4 Preservative: 0.05% Sodium azide Constituents: PBS, 50% Glycerol (glycerin, glycerine)
运输条件
Blue Ice
推荐的短期储存时间
1-2 weeks
推荐的短期储存条件
+4°C
推荐的长期储存条件
-20°C
分装信息
Upon delivery aliquot
储存信息
Avoid freeze / thaw cycle

补充信息

This supplementary information is collated from multiple sources and compiled automatically.

SIGLEC15 also known as sialic acid-binding Ig-like lectin 15 is a transmembrane protein with an approximate mass of 50 kDa. This protein is a member of the SIGLEC family that binds sialic acids on glycoproteins and glycolipids. SIGLEC15 is highly expressed in cells of the osteoclast lineage and some other immune cells. It typically functions as a receptor that can modulate immune cell interactions and signaling by recognizing and binding to sialylated glycans on other cells.
Biological function summary

SIGLEC15 plays roles in modulating the immune system and bone remodeling processes. It is not usually part of a larger complex but primarily acts as a cell surface receptor. SIGLEC15 helps regulate osteoclast differentiation and activity which are important for maintaining bone homeostasis. It modulates immune responses by interacting with other immune cells which can dampen or activate immune signaling pathways based on the cellular context.

Pathways

SIGLEC15 influences both immune signaling and bone metabolism pathways. It is involved in the RANKL-mediated osteoclastogenesis pathway which is critical for the formation and activation of osteoclasts. Within these pathways SIGLEC15 can relate to other proteins like RANK and RANKL that are essential in osteoclast development and function. Through its expression and interactions SIGLEC15 plays key roles in the regulation of immune and skeletal systems.

SIGLEC15 plays a significant role in osteoporosis and certain cancers. In osteoporosis SIGLEC15 expression in osteoclasts is elevated which can lead to increased bone resorption and weakened bones. In cancer its expression on tumor-associated macrophages and other cells can help tumors evade immune surveillance. In such conditions proteins like RANK RANKL and other immune checkpoint proteins may also be implicated providing potential targets for therapeutic intervention alongside SIGLEC15.

产品实验方案

For this product, it's our understanding that no specific protocols are required. You can visit:

靶点信息

Binds sialylated glycoproteins.
See full target information SIGLEC15

文献 (12)

Recent publications for all applications. Explore the full list and refine your search

Bioengineering & translational medicine 9:e10651 PubMed39553435

2024

Siglec15/TGF-β bispecific antibody mediates synergistic anti-tumor response against 4T1 triple negative breast cancer in mice.

Applications

Unspecified application

Species

Unspecified reactive species

Limei Shen,Alison M Schaefer,Karthik Tiruthani,Whitney Wolf,Samuel K Lai

The Journal of cell biology 223: PubMed39352498

2024

Organization of a cytoskeletal superstructure in the apical domain of intestinal tuft cells.

Applications

Unspecified application

Species

Unspecified reactive species

Jennifer B Silverman,Evan E Krystofiak,Leah R Caplan,Ken S Lau,Matthew J Tyska

Histology and histopathology 40:571-584 PubMed39301699

2024

Expression feature and prognostic function of a novel immune checkpoint Siglec-15 in human colorectal cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Guodong Liang,Linyun Zhou,Yang Fan,Run Ding,Junrong Yang,Li Xu,Yidan Zhu,Wen Huang

The clinical respiratory journal 18:e13772 PubMed38725348

2024

The expression characteristic and prognostic role of Siglec-15 in lung adenocarcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Haijun Sun,Qilong Du,Yuyu Xu,Cheng Rao,Li Xu,Junrong Yang,Yuan Mao,Lin Wang

Frontiers in immunology 14:1065062 PubMed37325664

2023

Siglec15 is a prognostic indicator and a potential tumor-related macrophage regulator that is involved in the suppressive immunomicroenvironment in gliomas.

Applications

Unspecified application

Species

Unspecified reactive species

Jinchao Wang,Linzong Xu,Qian Ding,Xiaoru Li,Kai Wang,Shangchen Xu,Bin Liu

Frontiers in endocrinology 13:1055826 PubMed36506053

2022

Immunosuppressive environment in response to androgen deprivation treatment in prostate cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Caipeng Qin,Jing Wang,Yiqing Du,Tao Xu

Current oncology (Toronto, Ont.) 29:7655-7671 PubMed36290882

2022

Siglec-15 as a New Perspective Therapy Target in Human Giant Cell Tumor of Bone.

Applications

Unspecified application

Species

Unspecified reactive species

Mengke Fan,Guochuan Zhang,Mingfang Xie,Xinbo Liu,Qi Zhang,Ling Wang

Scientific reports 12:10401 PubMed35729260

2022

Prognostic value of PD-L1 and Siglec-15 expression in patients with nasopharyngeal carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Ju Zhao,Hanshan Yang,Hui Hu,Chao Liu,Min Wei,Yumei Zhao,Yudan Chen,Yongxia Cui,Ping Chen,Kang Xiong,Yun Lu,Hongru Yang,Linglin Yang

The journal of pathology. Clinical research 8:268-278 PubMed35083884

2022

Analysis of a novel immune checkpoint, Siglec-15, in pancreatic ductal adenocarcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Xianlong Chen,Shengwei Mo,Yue Zhang,Heng Ma,Zhaohui Lu,Shuangni Yu,Jie Chen

Frontiers in oncology 11:710689 PubMed34336699

2021

Siglec-15 Promotes Tumor Progression in Osteosarcoma DUSP1/MAPK Pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Meng-Ke Fan,Guo-Chuan Zhang,Wei Chen,Li-Li Qi,Ming-Fang Xie,Yue-Yao Zhang,Ling Wang,Qi Zhang
View all publications

Abcam Product Promise

我们致力于为您的研究提供高质量的试剂,为您科研的每一步提供支持。若我们的产品未能达到预期性能,我们向您提供 Abcam Product Promise 保障。
详情请参阅我们的条款与条件。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com